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Abstract
Background: A 32 year-old African-American man presented to our institution after attempting
suicide via ingestion with quetiapine. He had reported a history of several days of substance abuse
with alcohol, cocaine and marijuana related to a partying binge. Following this, his partner removed
him from his residence resulting in a suicide attempt. During hospitalization the patient developed
priapism, a condition he had not experienced before.
Case presentation: Given this was his first time with priapism, an extensive work-up revealed
the patient had previously undiagnosed sickle cell trait, which we postulate to have been a
significant factor in his development of acute priapism. Sickle cell trait is considered to be a
generally benign condition except for a few rare complications under more demanding physical
conditions. However, upon reviewing the literature on the association of sickle cell trait with
priapism, we believe this may not be the case. Case reports and small series that appeared in the
1960s and 1970s indicated an association between priapism and sickle trait. Little has been
reported recently, and the general teaching regarding sickle cell trait does not include this
information. However, one case was reported with the use of phosphodiesterase-5 (PDE-5)
inhibitors and the development of priapism in a patient with sickle cell trait. These medications are
now first line treatment in erectile dysfunction. They act by enhancing nitric oxide (NO)
production leading to relaxation of smooth muscle in the corpora cavernosa and penile arteries.
Conclusion: Priapism was not reported in the initial studies of these medications. Further review
of the literature indicates this may be a complex relationship. Interestingly, PDE5 inhibitors also
have been postulated to be protective in sickle cell disease and perhaps also sickle cell trait because
priapism might be caused by reduced NO availability. In this article, we examine the evidence linking
sickle cell trait to priapism, explore the implications of PDE5 use, particularly in the setting of sickle
cell trait, and propose that teaching about sickle cell trait include a discussion of priapism risk.
Case presentation
A 32 year-old African-American man with a history of sub-
stance abuse, type-2 diabetes mellitus and hypertension
presented with mental status changes. He reported using
cocaine, alcohol and marijuana for several days, and then
attempted suicide by ingesting approximately 7 – 9
quetiapine tablets. He was treated with charcoal, rapid
sequence intubation with succinylcholine, etomidate, and
vecuronium, midazolam and propofol for sedation. Com-
plete blood count, serum chemistries, blood cultures,
Published: 30 December 2008
Cases Journal 2008, 1:429 doi:10.1186/1757-1626-1-429
Received: 30 September 2008
Accepted: 30 December 2008
This article is available from: http://www.casesjournal.com/content/1/1/429
© 2008 Birnbaum and Pinzone; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cases Journal 2008, 1:429 http://www.casesjournal.com/content/1/1/429
Page 2 of 3
(page number not for citation purposes)
ammonia level, liver function tests and head computed
tomography were normal except for potassium 2.9 and
creatinine of 1.2. Blood level for alcohol 0.088, acetami-
nophen < 0.1, and salicylate < 4. Electrocardiogram
showed a heart rate of 125 bpm and QTc interval of 500
milliseconds. The patient developed a persistent erection
during insertion of a Foley catheter, with no history of pri-
apism. Medications prior to admission included quetiap-
ine, amlodipine, atorvastatin, quinapril, glipizide,
duloxetine and divalproex sodium, though he was not
taking them regularly. Exam was notable for blood pres-
sure 180/101, heart rate 103, respiratory rate 18, and
moderate distress secondary to penile pain. Penis was tur-
gid with pallor, and testes were descended bilaterally and
normal in size and consistency. Phenylephrine was
injected into the penis without relief. Subsequently,
approximately 800 mL of blood was aspirated from the
corpora cavernosum, but turgidity remained unchanged.
The following day phenylephrine injection and aspiration
of blood were repeated, with a substantial decrease in tur-
gidity, though a partial erection remained for several more
days with an estimated 30% erection at discharge. Work-
up included a hemoglobin (Hb) electrophoresis which
demonstrated HbS 34.8%, HbA 60.5%, and HbA2 4.2%,
consistent with sickle cell trait.
Erectile function and sickle cell trait
Sickle cell trait involves one normal beta-globin chain and
one HbS chain, and is typically a benign condition. In
general, priapism is not believed to be associated; how-
ever, we suspect that sickle cell trait is an important pre-
disposing factor for priapism.
A normal erection occurs with increased blood flow to the
corpera cavernosa and reduced outflow. Potential mecha-
nisms for vascular occlusion in sickle cell disease include
microvascular occlusion by sickled erythrocytes, vascular
intimal hyperplasia, thrombosis and thromboembolism,
fat embolism and vasospasm or failure of compensatory
vasodilation. Microvascular occlusion is most important,
and is caused by deoxygenated irreversibly sickled eryth-
rocytes that have increased viscosity and endothelial
adherence. Some erythrocytes are believed to polymerize
even at normal arterial oxygen levels, and red blood cell
dehydration may also play a role. Increased endothelial
adherence may relate to sialic acid abnormalities, oxida-
tive membrane damage, loss of membrane phospholipid
asymmetry and binding to plasma proteins. Vascular inti-
mal hyperplasia is a cause of cerebral vascular accidents in
sickle cell disease, and it may be a factor in priapism. [1]
"Low flow" priapism may result from decreased penile
venous NO concentration resulting in vasoconstriction,
reduced blood flow, deoxygenation and sickling. [2] Sick-
ling promotes a vicious cycle resulting in reduced blood
flow and worsening deoxygenation.
A series of patients with priapism published in 1961
included a single case of priapism in a 39 year-old with
sickle cell trait. The patient was treated with anticoagula-
tion, ice and sedation initially, followed by aspiration and
irrigation on the third day. [3] Another case involved a 27
year-old man with 24 hours of priapism after vigorous
coitus. Treatment with anticoagulation and anesthesia
was unsuccessful, and was followed by evacuation of the
corpora cavernosa. [4] Subsequent reports include a 20
year-old male who sustained an accidental kick to the
shaft of his penis following intercourse with his wife, and
after 48-hours sought medical attention. Cold showers
and ethyl chloride spray did not work. Blood work indi-
cated HbA 54.9%, HbA2 4.5%, HbS 39.6%, and HbF 1.0%
consistent with sickle cell trait. Blood was evacuated from
the corpora and showed 95% sickling. Priapism returned
and whole blood transfusions showed no improvement.
Bilateral greater saphenous vein to corpus cavernosum
shunts resulted in slight improvement. A continuous pres-
sure dressing was applied, resulting in a 20% decrease in
size, but there was little improvement over the next 17
days. Continuous vacuum drainage led to complete reso-
lution of the erection over a week. Within 25 days postop-
eratively two spontaneous nocturnal erections associated
with orgasm were experienced, and 10 months following
discharge the patient reported having completely satisfac-
tory intercourse despite only partial erections. [5]
A 37 year-old man presented with acute priapism for 36
hours following sexual activity. [6] Masturbation did not
alleviate his symptoms. He had two similar episodes pre-
viously. Hemoglobin electrophoresis indicated HbA
57.3% and HbS 42.7%. He was placed on bedrest and
sedated, and penile ice packs were applied with no signif-
icant improvement. On hospital day eight bilateral aspira-
tion of blood from the corpus cavernosa and irrigation
with heparinized saline had an immediate partial
response, but a return to full erection within two hours.
Intravenous infusion of low molecular weight dextran for
five days following the failed aspiration had no response.
The patient was then offered a saphenous vein to corpus
cavernosum shunt which resulted in flaccidity during the
procedure, but continuation of the erection for six days
postoperatively, and then a return to flaccidity.
A 14 year-old boy with priapism of seven days duration
was found to have sickle cell trait and was treated initially
with aspiration with a large bore needle, then with a
sapheno-crural shunt. Three days following the shunt pro-
cedure, there was loss of the skin of the penile shaft and
glans that was treated with split thickness skin grafting.
The treatment resulted in 80% flaccidity; however, there
was a left shift of the penile shaft secondary to fibrosis,
thought to be caused by the shunt. [7]Cases Journal 2008, 1:429 http://www.casesjournal.com/content/1/1/429
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Of a series of 23 cases of priapism, one had sickle cell trait;
a 34 year-old with forty hours of turgidity following inter-
course, who had an episode three months earlier treated
with fibrinolysin (a bovine extract that causes fibrinoly-
sis), aspiration and anticoagulation. [8] His current epi-
sode was treated with analgesics, heparinized saline
followed by a sapheno-corporeal anastomosis. A blood
pressure cuff and pressure dressing was applied. Catheter-
ization took place on the second day along with ongoing
anticoagulation, and the erection resolved within five
days of this procedure. He then had satisfactory inter-
course with one prolonged erection eleven months post-
operatively that lasted six hours and spontaneously
resolved.
Perhaps the most convincing evidence of a link between
priapism and sickle cell trait was a report of 46 cases where
7 of the 24 (29%) African-Americans had sickle cell trait.
Of the patients with sickle cell trait, four were treated with
aspiration, two medically, and one with a shunt. [9]
Erectile function and medications
Various medications have been used for erectile dysfunc-
tion, however the most commonly used are the phos-
phodiesterase-5 (PDE5) inhibitors sildenafil, tadalafil
and vardenafil. [10] These medications are thought to
enhance production of NO, which leads to the relaxation
of the smooth muscle in the corpora cavernosa and penile
arteries. There were no reports of priapism with these
medications during initial studies; however, subsequently
a report of acute priapism with sildenafil in a patient with
sickle cell trait raised some concern. [11]
In contrast, one group postulates that PDE5 inhibitors
may actually protect against priapism in sickle cell disease,
because priapism might be a manifestation of reduced
NO availability. [2] Therefore, it seems logical to also
explore whether arginine or inhaled NO might also be
beneficial. In fact, one group proposed that self-manage-
ment of priapism might work best. The report cites a 38
year-old man with sickle cell trait and recurrent priapism
who treated prolonged erections with self-injection of
metaraminol for a period of 12 years, injecting as often as
once every other day. [12] Over this period, he did not
report to the emergency room, has not had any systemic
side effects, and has not shown any signs of fibrosis at the
injection site.
The patient had taken a number of medications and illicit
drugs prior to receiving medical care, and had a number
of medications administered while receiving care. Of the
medications that he reported taking or were given to him,
quetiapine, propofol, cocaine, alcohol, and marijuana
have been associated with priapism.
Discussion
There are multiple possible etiologies of the patient's pri-
apism; however, it appears that sickle cell trait was likely a
predisposing factor and we believe that this represents an
important public health issue. In light of the explosive use
of PDE5 inhibitors, we believe that studies need to inves-
tigate the potential association between sickle cell trait
and priapism, and how treatments for erectile dysfunction
play into this relationship. Moreover, the classical teach-
ing that sickle cell trait is a benign condition should be
reconsidered.
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